Biotechnology This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 16.

Ceterix topped last week's 5 biggest Silicon Valley fundings
Ceterix Orthopaedics Inc., a developer of surgical tools for arthroscopic procedures, was last week's biggest venture investment disclosed in Silicon Valley. The Menlo Park company said it raised $19.5 million in series B financing in a round led by new investor Novo Ventures. Previous investors Versant Ventures and 5AM Ventures also participated in the round. In connection with the financing, Peter Bisgaard, partner with Novo Ventures, joined the company's board. John McCutcheon is president…
Source: bizjournals.com Health Care:Biotechnology headlines - January 28, 2013 Category: Biotechnology Authors: Cromwell Schubarth Source Type: research

DaVita to provide dialysis at Jamestown hospital
WCA Hospital is shifting responsibility of its dialysis treatment center to a national company. Bronx Dialysis Center, an affiliate of DaVita Inc. of Denver, Colo., filed plans in early January with the state Health Department to certify WCA’s 18-station chronic renal dialysis extension clinic. The center is currently operating within WCA on Foote Avenue in Jamestown. In an open letter to the WCA community, hospital CEO Betsy Wright said the transition will help the hospital deal with the implementation…
Source: bizjournals.com Health Care:Biotechnology headlines - January 28, 2013 Category: Biotechnology Authors: Tracey Drury Source Type: research

Rubitection turns to the crowd for funding help
Another Pittsburgh entrepreneur is taking to the crowd to look for funding, but this time, it’s for a much more capital-intensive endeavor: A medical device startup. Compared to software startups, life sciences companies can take a longer time frame and more capital to get off the ground. It’s just this paradigm that has Sanna Gaspard embarking on a fundraising campaign for her company Rubitection Inc. on the website Indiegogo. Gaspard is looking to raise $250,000 so she can continue to develop…
Source: bizjournals.com Health Care:Biotechnology headlines - January 28, 2013 Category: Biotechnology Authors: Malia Spencer Source Type: research

Highly efficient production of the Alzheimer's γ‐secretase integral membrane protease complex by a multi‐gene stable integration approach
Abstract Inefficient production of membrane‐embedded multi‐protein complexes by conventional methods has largely prevented the generation of high‐resolution structural information and the performance of high‐throughput drug discovery screens for this class of proteins. Not exempt from this rule is γ‐secretase, an intramembrane‐cleaving protease complex regulating a multitude of signaling pathways and biological processes by influencing gene transcription. γ‐Secretase is also implicated in the pathogenesis of Alzheimer's disease and several types of cancer. As an additional challenge, the reconstitution of t...
Source: Biotechnology and Bioengineering - January 28, 2013 Category: Biomedical Science Authors: Jean‐René Alattia, Mattia Matasci, Mitko Dimitrov, Lorène Aeschbach, Sowmya Balasubramanian, David L. Hacker, Florian M. Wurm, Patrick C. Fraering Tags: Article Source Type: research

Biogen 4Q Profit Slips on Tax Hit, Rising Costs
From Associated Press (January 28, 2013) WESTON, Mass. -- Biogen Idec’s fourth-quarter earnings slipped nearly 3 percent after it fixed a tax error and saw expenses climb. The biotech drug maker said Monday that its tax expense increased by...
Source: Drugs.com - Pharma News - January 28, 2013 Category: Pharmaceuticals Source Type: news

From multi-omics to basic structures of biological systems.
PMID: 23273659 [PubMed - in process]
Source: Current Opinion in Biotechnology - January 28, 2013 Category: Biotechnology Authors: Müller S, Hiller K Tags: Curr Opin Biotechnol Source Type: research

Metaproteome analysis of the microbial communities in agricultural biogas plants.
Abstract In biogas plants agricultural waste and energy crops are converted by complex microbial communities to methane for production of renewable energy. In Germany, this process is widely applied namely in context of agricultural production systems. However, process disturbances, are one of the major causes for economic losses. In addition, the conversion of biomass, in particular of cellulose, is in most cases incomplete and, hence, insufficient. Besides technical aspects, a more profound characterization concerning the functionality of the microbial communities involved would strongly support the improvement o...
Source: New Biotechnology - January 28, 2013 Category: Biotechnology Authors: Heyer R, Kohrs F, Benndorf D, Rapp E, Kausmann R, Heiermann M, Klocke M, Reichl U Tags: N Biotechnol Source Type: research

From functional genomics to personalised medicine: Ten years of an ESF Research Networking Programme.
PMID: 23369866 [PubMed - as supplied by publisher]
Source: New Biotechnology - January 28, 2013 Category: Biotechnology Authors: Steinhausen K Tags: N Biotechnol Source Type: research

Advances in therapeutic RNA-targeting.
Abstract This paper reviews the advances in the past decade of different applications of modulating the level and content of mRNA by antisense oligonucleotide (AON)-based exon skipping. The primary aim of such modulation is the correction of genetic defects by alteration of the resulting protein such that the dysfunction is reduced or relieved. This application is in several clinical phase III trails, notably for Duchenne muscular dystrophy and earlier clinical trials are in preparation for other diseases, a.o. spinal muscular atrophy. An alternative aim may be to disrupt the reading frame of dysfunctional proteins...
Source: New Biotechnology - January 28, 2013 Category: Biotechnology Authors: van Ommen GJ, Aarstma-Rus A Tags: N Biotechnol Source Type: research

Cell signaling analyses in the functional genomics era.
Abstract The advancements in proteomics over the past decade have brought tremendous increases in sensitivity of mass spectrometry (MS) analyses and new technologies such as methods for quantitative MS and phosphoproteomics. The development of antibodies targeting a large fraction of the human proteome as well as specific antibodies that detect phosphorylations and other post-translational modifications now allows detection of a great variety of signaling marks. Combined with medium and high throughput methods for detecting many parallel signaling events such as phospho-flow cytometry analyses and MS-based analyses...
Source: New Biotechnology - January 28, 2013 Category: Biotechnology Authors: Rogne M, Taskén K Tags: N Biotechnol Source Type: research

Chromosomal evolution of Escherichia coli for the efficient production of lycopene
Conclusions: A lycopene hyper-producer E. coli strain that does not carry a plasmid or antibiotic marker was constructed using triclosan-induced chromosomal evolution. The methods detailed in this study can be used to engineer E. coli to produce other metabolites.
Source: BMC Biotechnology - Latest articles - January 28, 2013 Category: Biotechnology Authors: Yun-Yan ChenHong-Jie ShenYan-Yan CuiShang-Guang ChenZhi-Ming WengMing ZhaoJian-Zhong Liu Source Type: research

Effects of short elastin‐like peptides on filamentous particles and their transition behavior
Abstract While elastin‐like polypeptides and peptides (ELPs) have been used for various stimulus‐responsive applications, details of their switching remain unclear. We therefore constructed a novel series of filamentous phage particles displaying a high surface density of short ELPs. The surface display of ELPs did not disrupt either particle shape or dimensions, and the resulting ELP‐phage particles were colloidally stable over several weeks. However, in spite of a saturating surface density, macroscopic aggregation of ELP‐phages cannot be triggered in water. To investigate the underlying mechanisms we examined co...
Source: Biotechnology and Bioengineering - January 28, 2013 Category: Biomedical Science Authors: Adam P. Hathorne, Harry Bermudez Tags: Article Source Type: research

Remote delivery of hydroxyl radicals via secondary chemistry of a nonthermal plasma effluent
Abstract Electron paramagnetic resonance spectroscopy is used to observe hydroxyl radicals produced by an atmospheric pressure nonthermal plasma device at distances greater than one meter from the discharge. The plasma device is an indirect treatment setup with closed loop air flow and hydrogen peroxide additives that is effective in deactivating bacteria on time scales of seconds. The generation of the detected hydroxyl radicals is shown to occur in secondary chemical processes near the point of delivery of the plasma treated air stream. The production of hydroxyl radicals is correlated with humidity of the air stream and...
Source: Biotechnology and Bioengineering - January 28, 2013 Category: Biomedical Science Authors: S. Reed Plimpton, Mark Gołkowski, Deborah G. Mitchell, Chad Austin, Sandra S. Eaton, Gareth R. Eaton, Czeslaw Gołkowski, Martin Voskuil Tags: Article Source Type: research

Induced effect of Na+ on ganoderic acid biosynthesis in static liquid culture of Ganoderma lucidum via calcineurin signal transduction
Abstract Na+/Ca2+ exchange is important to cell physiology and metabolism, but its role in the secondary metabolite biosynthesis by fungi is yet unclear. In this work, in static liquid cultures of G. lucidum, which is an efficient process for hyper‐production of anti‐tumor ganoderic acids (GAs), it was interestingly found that Na+ addition could enhance the GAs production, but K+ did not. Further investigation by intracellular Ca2+ imaging and using a calcineurin inhibitor (i.e., cyclosporin A) revealed that addition of Na+ led to the influx of Ca2+ from culture broth to the cells and calcineurin signals were also trig...
Source: Biotechnology and Bioengineering - January 28, 2013 Category: Biomedical Science Authors: Yi‐Ning Xu, Xiao‐Xia Xia, Jian‐Jiang Zhong Tags: Article Source Type: research

DIPP planning to issue CL for 3 anti-cancer drugs
"The DIPP is expected to ask for some more details from different ministries, including the Health Ministry," the source added.
Source: The Economic Times Healthcare and Biotech News - January 27, 2013 Category: Pharmaceuticals Source Type: news

Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening
Nature Biotechnology 31, 154 (2013). doi:10.1038/nbt.2462 Authors: Silin Zhong, Zhangjun Fei, Yun-Ru Chen, Yi Zheng, Mingyun Huang, Julia Vrebalov, Ryan McQuinn, Nigel Gapper, Bao Liu, Jenny Xiang, Ying Shao & James J Giovannoni
Source: Nature Biotechnology - January 27, 2013 Category: Biotechnology Authors: Silin ZhongZhangjun FeiYun-Ru ChenYi ZhengMingyun HuangJulia VrebalovRyan McQuinnNigel GapperBao LiuJenny XiangYing ShaoJames J Giovannoni Tags: Research Source Type: research

Evaluation of methods for modeling transcription factor sequence specificity
Nature Biotechnology 31, 126 (2013). doi:10.1038/nbt.2486 Authors: Matthew T Weirauch, Atina Cote, Raquel Norel, Matti Annala, Yue Zhao, Todd R Riley, Julio Saez-Rodriguez, Thomas Cokelaer, Anastasia Vedenko, Shaheynoor Talukder, Phaedra Agius, Aaron Arvey, Philipp Bucher, Curtis G Callan, Cheng Wei Chang, Chien-Yu Chen, Yong-Syuan Chen, Yu-Wei Chu, Jan Grau, Ivo Grosse, Vidhya Jagannathan, Jens Keilwagen, Szymon M Kiełbasa, Justin B Kinney, Holger Klein, Miron B Kursa, Harri Lähdesmäki, Kirsti Laurila, Chengwei Lei, Christina Leslie, Chaim Linhart, Anand Murugan, Alena Myšičková, Will...
Source: Nature Biotechnology - January 27, 2013 Category: Biotechnology Authors: Matthew T WeirauchAtina CoteRaquel NorelMatti AnnalaYue ZhaoTodd R RileyJulio Saez-RodriguezThomas CokelaerAnastasia VedenkoShaheynoor TalukderPhaedra AgiusAaron ArveyPhilipp BucherCurtis G CallanCheng Wei ChangChien-Yu ChenYong-Syuan ChenYu-Wei ChuJan Gr Tags: Computational Biology Source Type: research

"Colloids Surf B Biointerfaces"[ta]; +137 new citations
137 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: "Colloids Surf B Biointerfaces"[ta] These pubmed results were generated on 2013/01/26PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.
Source: Colloids and Surfaces - January 26, 2013 Category: Biotechnology Tags: Report Source Type: research

"Bioresour Technol"[ta]; +441 new citations
441 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: "Bioresour Technol"[ta] These pubmed results were generated on 2013/01/26PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.
Source: Bioresource Technology - January 26, 2013 Category: Biotechnology Tags: Report Source Type: research

Heartland Cardiology to add 3 Cypress Heart physicians
Heartland Cardiology PA is adding three cardiologists from Cypress Heart. The transition will take place April 1. This is an update and confirmation to a post from early Friday afternoon. With the additions, Heartland Cardiology will have 11 cardiologists, making it the largest cardiology clinic in Wichita. Joining Heartland are Drs. Roger Evans, Hussam Farhoud and Shilpa Kshatriya. I’m told that the Cypress name won’t go away, nor will its location at 29th Street North and Webb Road. Heartland…
Source: bizjournals.com Health Care:Biotechnology headlines - January 26, 2013 Category: Biotechnology Authors: Josh Heck Source Type: research

Immobilization of nisin producer Lactococcus lactis strains to chitin with surface-displayed chitin-binding domain.
In this study, nisin producer Lactococcus lactis strains displaying cell surface chitin-binding domain (ChBD) and capable of immobilizing to chitin flakes were constructed. To obtain ChBD-based cell immobilization, Usp45 signal sequence with ChBD of chitinase A1 enzyme from Bacillus circulans was fused with different lengths of PrtP (153, 344, and 800 aa) or AcmA (242 aa) anchors derived from L. lactis. According to the whole cell ELISA analysis, ChBD was successfully expressed on the surface of L. lactis cells. Scanning electron microscope observations supported the conclusion of the binding analysis that L. lactis cells ...
Source: Applied Microbiology and Biotechnology - January 26, 2013 Category: Microbiology Authors: Simşek O, Sabanoğlu S, Con AH, Karasu N, Akçelik M, Saris PE Tags: Appl Microbiol Biotechnol Source Type: research

Prevention of quorum-sensing-mediated biofilm development and virulence factors production in Vibrio spp. by curcumin.
Abstract The increasing occurrence of disease outbreaks caused by Vibrio spp. and the emergence of antibiotic resistance has led to a growing interest in finding alternative strategies to prevent vibriosis. Since the pathogenicity of vibrios is controlled in part by quorum-sensing (QS) system, interfering with this mechanism would prevent the pathogenicity of vibrios without developing resistance. Hence, a non-toxic phytochemical curcumin from Curcuma longa was assessed for its potential in reducing the production of QS-dependent virulence factors in Vibrio spp. The obtained results evidenced 88 % reduction in bio...
Source: Applied Microbiology and Biotechnology - January 26, 2013 Category: Microbiology Authors: Packiavathy IA, Sasikumar P, Pandian SK, Veera Ravi A Tags: Appl Microbiol Biotechnol Source Type: research

Loop engineering of amadoriase II and mutational cooperativity.
In this study, amadoriase II, a member of the FAOX family from Aspergillus fumigatus was engineered to broaden its substrate range using a modified combinatorial active site saturation testing approach. The two loops at the entrance of the substrate channel were targeted. Saturation mutagenesis was carried out to search for hot-spot sites, followed by pairwise mutagenesis and subsequent combination of active mutations. Five sites on the loops were found to be critical for accessibility for two model bulky substrates, fructosyl adamantanamine and fructosyl-polylysine (3-13 lysines). Two best mutants (with three and five mut...
Source: Applied Microbiology and Biotechnology - January 26, 2013 Category: Microbiology Authors: Qian Y, Zheng J, Lin Z Tags: Appl Microbiol Biotechnol Source Type: research

Use of propidium monoazide and increased amplicon length reduce false-positive signals in quantitative PCR for bioburden analysis.
In this study, we assessed the capability of propidium monoazide (PMA) to inactivate exogenous DNA in PCR reagents and thus to minimise its impact in bioburden analysis. PMA is a membrane-impermeant dye that intercalates into DNA and covalently binds to it upon photoactivation leading to strong inhibition of PCR amplification. PMA is currently used mainly for treatment of microbiological samples to exclude signals from membrane-compromised cells, but is also very useful for suppression of exogenous DNA signals. In addition to testing the effect of different PMA concentrations on non-template controls and target DNA, we dem...
Source: Applied Microbiology and Biotechnology - January 26, 2013 Category: Microbiology Authors: Schnetzinger F, Pan Y, Nocker A Tags: Appl Microbiol Biotechnol Source Type: research

Modification of histidine biosynthesis pathway genes and the impact on production of L-histidine in Corynebacterium glutamicum.
This study represents the first attempt to substitute the histidine biosynthesis pathway promoter in the chromosome with a stronger promoter to increase histidine production. PMID: 23355034 [PubMed - as supplied by publisher]
Source: Biotechnology Letters - January 26, 2013 Category: Biotechnology Authors: Cheng Y, Zhou Y, Yang L, Zhang C, Xu Q, Xie X, Chen N Tags: Biotechnol Lett Source Type: research

Piper nigrum: Micropropagation, Antioxidative enzyme activities, and Chromatographic Fingerprint Analysis for Quality Control.
Abstract A reliable in vitro regeneration system for the economical and medicinally important Piper nigrum L. has been established. Callus and shoot regeneration was encouraged from leaf portions on Murashige and Skoog (MS) medium augmented with varied concentrations of plant growth regulators. A higher callus production (90 %) was observed in explants incubated on MS medium incorporated with 1.0 mg L(-1) 6-benzyladenine (BA) along with 0.5 mg L(-1) gibberellic acid after 4 weeks of culture. Moreover, a callogenic response of 85 % was also recorded for 1.0 mg L(-1) BA in combination with 0.25 mg L(-1...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Ahmad N, Abbasi BH, Rahman IU, Fazal H Tags: Appl Biochem Biotechnol Source Type: research

Heterotrophic Nitrifying and Oxygen Tolerant Denitrifying Bacteria from Greenwater System of Coastal Aquaculture.
Abstract In this work, herbivorous fish Mugil cephalus has been cultured to secrete protein rich green slime, which helps nitrifying and oxygen tolerant denitrifying bacteria to grow and colonize. Four strains representing Alcaligenaceae family have been isolated from greenwater system and characterized using biochemical test, fatty acid methyl ester (GC-FAME) analysis, 16S rRNA and functional gene approaches. They were tested for an ability to nitrify ammonia and nitrite aerobically. Two strains showed notable nitrification activity, when grown in a mineral salts medium containing ammonium sulfate and potassium ni...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Velusamy K, Krishnani KK Tags: Appl Biochem Biotechnol Source Type: research

Biodiesel Residual Glycerol Metabolism by Klebsiella pneumoniae: Pool of Metabolites Under Anaerobiosis and Oxygen Limitation as a Function of Feeding Rates.
Abstract The metabolism of residual glycerol from biodiesel synthesis by Klebsiella pneumoniae BLh-1 was investigated in this study. Batch and fed-batch cultivations were performed in bioreactors under anaerobic and oxygen limitation conditions. Results of batch cultivations showed that the main product was 1,3-propanediol (1,3-PD) in both conditions, although the higher yields and productivities (0.46 mol mol(-1) glycerol and 1.22 g L(-1) h(-1), respectively) were obtained under anaerobic condition. Large amounts of ethanol were also produced under batch anaerobic condition, peaking at 12.30 g L(-1). Batc...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Rossi DM, de Souza EA, Ayub MA Tags: Appl Biochem Biotechnol Source Type: research

Expression and Large-Scale Production of Human Tissue Plasminogen Activator (t-PA) in Transgenic Tobacco Plants Using Different Signal Peptides.
Abstract An attempt was made to assess the expression level and targeting of a human protein entitled recombinant tissue plasminogen activator (rt-PA) through accumulation in three cellular compartments including the endoplasmic reticulum and cytosolic and apoplastic spaces in transgenic tobacco plants. In this context, three chimeric constructs pBI-SP-tPA, pBI-tPA-KDEL, and pBI-Ext-tPA were employed and transferred into the tobacco plants through a popular transformation-based system called Agrobacterium tumefaciens. As an initial screening system, the incorporation of the rt-PA gene in the genomic DNA of tobacco ...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Goojani HG, Javaran MJ, Nasiri J, Goojani EG, Alizadeh H Tags: Appl Biochem Biotechnol Source Type: research

Expression of the Acid Protease Gene from Saccharomycopsis fibuligera in the Marine-Derived Yarrowia lipolytica for Both Milk Clotting and Single Cell Protein Production.
In this study, the native acid protease gene in Yarrowia lipolytica 22a-2 with high content of protein was disrupted, and the disruptant 3-13-10 obtained had very low acid protease activity. Then, the acid protease gene (AP1 gene) from Saccharomycopsis fibuligera A11 was actively expressed in the disruptant 3-13-10, and the transformant 43 carrying the AP1 gene had high specific acid protease activity (46.7 U/mg). The recombinant acid protease produced by the transformant 43 was found to be able to actively clot milk, and the transformant 43 still kept high content of protein. The hydrolysis products of κ-casein under ca...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Yu XJ, Chi Z, Wang F, Li J, Chi ZM, Madzak C Tags: Appl Biochem Biotechnol Source Type: research

Overproduction of Polygalacturonase by Penicillium griseoroseum Recombinant Strains and Functional Analysis by Targeted Disruption of the pgg2 Gene.
Abstract Inactivation of the pgg2 gene, a polygalacturonase-encoding gene from Penicillium griseoroseum, reduced the total activity of polygalacturonase (PG) by 90 % in wild-type P. griseoroseum, which indicates that the pgg2 gene is the major gene responsible for PG production in this species. To increase PG production, the coding region of the pgg2 gene was cloned under the control of the glyceraldehyde 3-phosphate dehydrogenase (gpd) promoter and the terminator region of the tryptophan synthase (trpC) gene from Aspergillus nidulans (pAN52pgg2 vector). This vector was then used to transform P. griseoroseum. The ...
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Teixeira JA, Ribeiro JB, Gonçalves DB, de Queiroz MV, de Araújo EF Tags: Appl Biochem Biotechnol Source Type: research

A New Trend on Biosensor for Neurotransmitter Choline/Acetylcholine-an Overview.
This study tries to give an overview of the present status of the material-based biosensor design and new generation of choline/acetylcholine neurotransmitter biosensors. PMID: 23354504 [PubMed - as supplied by publisher]
Source: Applied Biochemistry and Biotechnology - January 26, 2013 Category: Biochemistry Authors: Khan A, Khan AA, Asiri AM, Rub MA, Azum N, Rahman MM, Khan SB, Ghani SA Tags: Appl Biochem Biotechnol Source Type: research

Did You Get Your Vaccine Tattoo?
A recent Nature Materials paper reports on a surprising and somewhat contradictory-sounding approach for safe and painless vaccinations--microneedles. Actually, it's an array of very small needles. These can be coated with DNA or proteins, and then used to push the coating into the epidermal layer of the skin to introduce a layer of biologically active molecules where they can remain for days to weeks. This gives the body more time to respond, which can be useful for some drugs, such as vaccines. Basically, you're tattooing a layer of a drug just under the skin....Read Full Post
Source: About.com Biotech Biomedical - January 26, 2013 Category: Biotechnology Source Type: news

Gold Nanoparticle-Modified Carbon Electrode Biosensor for the Detection of Listeria monocytogenes
Industrial Biotechnology , Vol. 0, No. 0.
Source: Industrial Biotechnology - January 25, 2013 Category: Biotechnology Tags: article Source Type: research

Dr. Brad Vince of Kansas City Set to Attend a Number of Prominent...
Dr. Brad Vince of Vince & Associates Clinical Research in Kansas City, a leading provider of Phase I-III clinical trial research for the global pharmaceutical and biotech industry, has released a...(PRWeb January 25, 2013)Read the full story at http://www.prweb.com/releases/brad-vince/kansas-city/prweb10357906.htm
Source: PRWeb: Medical Pharmaceuticals - January 25, 2013 Category: Pharmaceuticals Source Type: news

Protection of genetic heritage in the era of cloning
Research on human beings has expanded greatly due to progress and the evolution of society as well as customs. Not only the unceasing development of research on human beings, but also interference in the beginning and end of life with homologous and heterogonous human reproduction, surrogate motherhood, cloning, gene therapies, eugenics,euthanasia, dysthanasia, orthothanasia, assisted suicide, genetic engineering, reassignment surgery in cases of transsexuality, the use of recombinant DNA technology and embryonic stem cells, transplantation of human organs and tissues, biotechnology and many other scientific advances. Scie...
Source: Revista Brasileira de Hematologia e Hemoterapia - January 25, 2013 Category: Hematology Source Type: research

Baptist Health names Hanson new CEO
Baptist Health, formerly Baptist Healthcare System Inc., has named Stephen C. Hanson president and CEO, effective March 8, according to a news release. He succeeds Tommy J. Smith, who announced his retirement last June. Smith has been an administrator with Baptist Healthcare for 37 years and has led the organization since 1995. Hanson, 61, has served in leadership positions for Texas Health Resources since 2005, most recently as executive vice president and operations leader for the region covering…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Source Type: research

Covered California to distribute $43M in grants, solicits applications
Covered California, the health benefits exchange set up to implement key parts of Obamacare in California, is soliciting applications for $43 million in grants. The initial application deadline is March 4. Depending on what response rate it gets, the exchange may ask for additional applications in late May. Its goal is to find community organizations to help it reach uninsured and "subsidy eligible" Californians who may not know about or understand the purpose of the exchange. The exchange's top…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Chris Rauber Source Type: research

Opexa closes private offering with $650,000 raised
The Woodlands-based Opexa Therapeutics Inc. (Nasdaq: OPXA) closed its private offering Jan. 23 after raising $650,000 in gross proceeds. Notes issued to investors will mature in January 2014 and will accrue 12 percent per year. Earlier this month the pharmaceutical company received a letter from the Nasdaq Market LLC informing the company it had regained minimum bid listing compliance. Opexa was notified in August the company's stock must be at least $1 per share for 10 consecutive trading days…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Bayan Raji Source Type: research

Presbyterian to lower broker commissions on small group business
Presbyterian Health Plan said Friday it is lowering the commission it pays insurance brokers for small group business. The commission for small group (50 employees or fewer) business will drop to 8 percent from 9 percent, said Neal Spero, Presbyterian’s vice president of sales and marketing. Presbyterian won’t change the commission rates for its large group business, Spero said. About 17,000 of Presbyterian’s 420,000 members belong to small groups, Spero added. The reason for the commission…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Dennis Domrzalski Source Type: research

UnitedHealth buys Boston IT firm; deal worth hundreds of millions: Report
UnitedHealth Group has bought Humedica, a privately held Boston-based health IT firm, two sources familiar with the deal confirmed Friday. The Boston Business Journal has the story about the deal, which is valued in the hundreds of million of dollars, according to one of the sources. >Click here to read more about the acquisition and Humedica's background. Humedica, which has raised at least $63 million and was launched in 2009, produces health analytics tools for hospitals, physician practices…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Ed Stych Source Type: research

St. Vincent's joins Brookwood in latest attempt to block Trinity move
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Yann Ranaivo Source Type: research

Kansas smoking ban hasn’t choked off bars, restaurants, study finds
The Kansas Health Institute has released an analysis saying the statewide smoking ban has not had an overall negative effect on the restaurant and bar industry, as some initially feared. The ban, implemented in July 2010 as a public health initiative, was intended to reduce the public’s exposure to secondhand smoke. KHI has compared sales and liquor license data for the eight years before the ban’s implementation as well as for the two years following. The analysis does note that individual…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Brianne Pfannenstiel Source Type: research

Susan Buettner leaves Aurora Health Care
Susan Buettner, a senior vice president at Aurora Health Care, has left the state’s largest health care system in what Aurora called a restructuring of her business unit. Buettner most recently was senior vice president of planning and innovation at Milwaukee-based Aurora. She previously held senior vice president positions in Aurora Health Services and Aurora Health Ventures. She also was president of Aurora Health Ventures. Buettner joined Aurora in 1992 and was a member of the system’s management…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Rich Kirchen Source Type: research

$289,000 grant helps SSM DePaul Health Center address adolescent depression
A $289,000 grant from the St. Louis County Children’s Services Fund will help fund a new SSM Behavioral Health Services program aimed at helping adolescents struggling with depression who lack health insurance. SSM DePaul Health Center is offering the new program starting Monday. It is designed for young adults ages 12 to 17 and a parent or parental figure to participate in intensive outpatient services. The services are offered five days a week, and the sessions are designed to strengthen the…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Samantha Liss Source Type: research

Biomarker-Based Nanotechnology for the Improvement of Reproductive Performance in Beef and Dairy Cattle
Industrial Biotechnology , Vol. 0, No. 0.
Source: Industrial Biotechnology - January 25, 2013 Category: Biotechnology Tags: article Source Type: research

In the Spotlight: Candice Rettie, Alzheimer's Association
This week's edition of In the Spotlight features Candice Rettie, vice president of programs and services at the Alzheimer's Association National Capital Area Chapter in Fairfax. Rettie most recently was vice president of education, professional advancement and training at the University of Maryland Biotechnology Institute. Want to be considered for a future In the Spotlight feature? Submit your announcements here or email nduhring@bizjournals.com. And be sure to check out People on the Move for…
Source: bizjournals.com Health Care:Hospitals headlines - January 25, 2013 Category: Hospital Management Authors: Charlotte Kelly Source Type: research

Dr Reddy's launches generic antihistamine tablets in US
Drug firm Dr Reddy's Laboratories today said it has launched generic antihistamine desloratadine tablets in the American market.
Source: The Economic Times Healthcare and Biotech News - January 25, 2013 Category: Pharmaceuticals Source Type: news

Biocon eyes Rs 100 cr from psoriasis drug
The product would be manufactured and formulated as an infusion drug at Biocon's biopharma manufacturing facility at Biocon Park, Bangalore.
Source: The Economic Times Healthcare and Biotech News - January 25, 2013 Category: Pharmaceuticals Source Type: news

Pipeline reveals 2013 entrepreneurial fellowship participants
Four of 13 entrepreneurs slated for Pipeline Inc.’s next fellowship hail from the Kansas City metropolitan area. The entrepreneur grooming organization announced who it had picked for its 2013 class Thursday night during the Pipeline Innovator of the Year reception at The Midland Theatre in Kansas City. Pipeline, which previously stayed within Kansas’ borders, opened the yearlong program to Missouri and Nebraska companies last year. Kansas City-area companies selected for the track were Keith…
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2013 Category: Biotechnology Authors: Alyson Raletz Source Type: research